Back to Search Start Over

Robotic Intracorporeal Padua Ileal Bladder: Surgical Technique, Perioperative, Oncologic and Functional Outcomes.

Robotic Intracorporeal Padua Ileal Bladder: Surgical Technique, Perioperative, Oncologic and Functional Outcomes.

Authors :
Simone G
Papalia R
Misuraca L
Tuderti G
Minisola F
Ferriero M
Vallati G
Guaglianone S
Gallucci M
Source :
European urology [Eur Urol] 2018 Jun; Vol. 73 (6), pp. 934-940. Date of Electronic Publication: 2016 Oct 22.
Publication Year :
2018

Abstract

Background: Robot-assisted radical cystectomy (RARC) with intracorporeal neobladder reconstruction is a challenging procedure. The need for surgical skills and the long operative times have led to concern about its reproducibility.<br />Objective: To illustrate our technique for RARC and totally intracorporeal orthotopic Padua ileal bladder.<br />Design, Setting, and Participants: From August 2012 to February 2014, 45 patients underwent this technique at a single tertiary referral centre.<br />Surgical Procedure: RARC, extended pelvic lymph node dissection, and intracorporeal partly stapled neobladder. Surgical steps are demonstrated in the accompanying video.<br />Measurements: Demographics, clinical, and pathological data were collected. Perioperative, 2-yr oncologic and 2-yr functional outcomes were reported.<br />Results and Limitations: Intraoperative transfusion or conversion to open surgery was not necessary in any case and intracorporeal neobladder was successfully performed in all 45 patients. Median operative time was 305min (interquartile range [IQR]: 282-345). Median estimated blood loss was 210ml (IQR: 50-250). Median hospital stay was 9 d (IQR: 7-12). The overall incidence of perioperative, 30-d and 180-d complications were 44.4%, 57.8%, and 77.8%, respectively, while severe complications occurred in17.8%, 17.8%, and 35.5%, respectively. Two-yr daytime and night-time continence rates were 73.3% and 55.5%, respectively. Two-yr disease free survival, cancer specific survival, and overall survival rates were 72.5%, 82.3%, and 82.4%, respectively. The small sample size and high caseload of the centre might affect the reproducibility of these results.<br />Conclusions: Our experience supports the feasibility of totally intracorporeal neobladder following RARC. Operative times and perioperative complication rates are likely to be reduced with increasing experience.<br />Patient Summary: We report the outcomes of our first 45 consecutive patients who underwent robot-assisted radical cystectomy with intracorporeal neobladders. Perioperative, oncologic, and functional outcomes support this technique as a feasible and safe surgical option in tertiary referral centres.<br /> (Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-7560
Volume :
73
Issue :
6
Database :
MEDLINE
Journal :
European urology
Publication Type :
Academic Journal
Accession number :
27780643
Full Text :
https://doi.org/10.1016/j.eururo.2016.10.018